» Articles » PMID: 17267788

Genetics of Recurrent Early-onset Major Depression (GenRED): Significant Linkage on Chromosome 15q25-q26 After Fine Mapping with Single Nucleotide Polymorphism Markers

Abstract

Objective: The authors studied a dense map of single nucleotide polymorphism (SNP) DNA markers on chromosome 15q25-q26 to maximize the informativeness of genetic linkage analyses in a region where they previously reported suggestive evidence for linkage of recurrent early-onset major depressive disorder.

Method: In 631 European-ancestry families with multiple cases of recurrent early-onset major depressive disorder, 88 SNPs were genotyped, and multipoint allele-sharing linkage analyses were carried out. Marker-marker linkage disequilibrium was minimized, and a simulation study with founder haplotypes from these families suggested that linkage scores were not inflated by linkage disequilibrium.

Results: The dense SNP map increased the information content of the analysis from around 0.7 to over 0.9. The maximum evidence for linkage was the Z likelihood ratio score statistic of Kong and Cox (Z(LR))=4.69 at 109.8 cM. The exact p value was below the genomewide significance threshold. By contrast, in the genome scan with microsatellite markers at 9 cM spacing, the maximum Z(LR) for European-ancestry families was 3.43 (106.53 cM). It was estimated that the linked locus or loci in this region might account for a 20% or less populationwide increase in risk to siblings of cases.

Conclusions: This region has produced modestly positive evidence for linkage to depression and related traits in other studies. These results suggest that DNA sequence variations in one or more genes in the 15q25-q26 region can increase susceptibility to major depression and that efforts are warranted to identify these genes.

Citing Articles

Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study.

Skiba A, Talarowska M, Szemraj J, Galecki P J Pers Med. 2021; 11(7).

PMID: 34357104 PMC: 8303668. DOI: 10.3390/jpm11070637.


Structural brain measures linked to clinical phenotypes in major depression replicate across clinical centres.

Yu M, Cullen N, Linn K, Oathes D, Seok D, Cook P Mol Psychiatry. 2021; 26(7):2764-2775.

PMID: 33589737 DOI: 10.1038/s41380-021-01039-8.


RNA editing blood biomarkers for predicting mood alterations in HCV patients.

Salvetat N, van der Laan S, Vire B, Chimienti F, Cleophax S, Bronowicki J J Neurovirol. 2019; 25(6):825-836.

PMID: 31332697 PMC: 6920238. DOI: 10.1007/s13365-019-00772-9.


Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents.

Chimienti F, Cavarec L, Vincent L, Salvetat N, Arango V, Underwood M Transl Psychiatry. 2019; 9(1):91.

PMID: 30770787 PMC: 6377659. DOI: 10.1038/s41398-018-0331-3.


Family History as an Important Factor for Stratifying Participants in Genetic Studies of Major Depression.

Zalar B, Blatnik A, Maver A, Klemenc-Ketis Z, Peterlin B Balkan J Med Genet. 2018; 21(1):5-12.

PMID: 30425904 PMC: 6231308. DOI: 10.2478/bjmg-2018-0010.